Cargando…
Cellular localization of nucleolin determines the prognosis in cancers: a meta-analysis
Nucleolin (NCL) is a multifunctional protein expressed in the nucleus, cytoplasm, and cell membrane. Overexpression of NCL has a controversial role as a poor prognostic marker in cancers. In this study, a meta-analysis was performed to evaluate the prognostic value of NCL in different subcellular lo...
Autores principales: | Yangngam, Supaporn, Prasopsiri, Jaturawitt, Hatthakarnkul, Phimmada, Thongchot, Suyanee, Thuwajit, Peti, Yenchitsomanus, Pa-thai, Edwards, Joanne, Thuwajit, Chanitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329415/ https://www.ncbi.nlm.nih.gov/pubmed/35861882 http://dx.doi.org/10.1007/s00109-022-02228-w |
Ejemplares similares
-
Nucleolin-based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)
por: Thongchot, Suyanee, et al.
Publicado: (2023) -
Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
por: Chuangchot, Nisa, et al.
Publicado: (2023) -
Carbonic anhydrase IX-related tumoral hypoxia predicts worse prognosis in breast cancer: A systematic review and meta-analysis
por: Numprasit, Warapan, et al.
Publicado: (2023) -
Establishment and characterization of novel highly aggressive HER2-positive and triple-negative breast cancer cell lines
por: Thongchot, Suyanee, et al.
Publicado: (2021) -
Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer
por: Thongchot, Suyanee, et al.
Publicado: (2022)